<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Patents in India</title>
	<atom:link href="http://healthcare-economist.com/2008/01/25/patents-in-india/feed/" rel="self" type="application/rss+xml" />
	<link>http://healthcare-economist.com/2008/01/25/patents-in-india/</link>
	<description>An unbiased look at today's health care issues</description>
	<pubDate>Tue, 02 Dec 2008 08:46:00 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.5</generator>
		<item>
		<title>By: Cavalcade of Risk #44: Risk Is Everywhere Edition</title>
		<link>http://healthcare-economist.com/2008/01/25/patents-in-india/#comment-131642</link>
		<dc:creator>Cavalcade of Risk #44: Risk Is Everywhere Edition</dc:creator>
		<pubDate>Wed, 30 Jan 2008 15:13:15 +0000</pubDate>
		<guid isPermaLink="false">http://healthcare-economist.com/2008/01/25/patents-in-india/#comment-131642</guid>
		<description>[...] Patents in India @ Healthcare Economist In their 2003 NBER working paper, Chaudhuri, Goldberg and Jia (CGJ) attempt to measure the welfare effects of pharmaceutical patent enforcement in India for the anti-bacterial category fluoroquinolones. [...]</description>
		<content:encoded><![CDATA[<p>[...] Patents in India @ Healthcare Economist In their 2003 NBER working paper, Chaudhuri, Goldberg and Jia (CGJ) attempt to measure the welfare effects of pharmaceutical patent enforcement in India for the anti-bacterial category fluoroquinolones. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
